Carter Bankshares, Inc. (CARE) AI Stock Analysis

NASDAQ: CAREAI research summary: business, growth, valuation, analysts, bull and bear case.

CARE AI stock analysis summary

AI Research

Carter Bankshares, Inc. (CARE) is the bank holding company for Carter Bank & Trust, operating in Virginia and North Carolina. In the trailing twelve months, the company generated $286.2M in revenue with an operating margin of 55.0% and a net profit margin of 44.9%. Over the past year, the stock gained 66.2%, outperforming the S&P 500 benchmark return of 16.8%.

Market cap
$699.8M
Revenue (TTM)
$286.2M
P/E
5.2x
fwd 13.7x
1Y return
66.2%
S&P 500 16.8%
Avg. target
$35.08
16.1% vs last close

Bull case

  • Quarterly revenue grew 68.3% year-over-year in the latest quarter ended June 30, 2026, while quarterly earnings jumped 253.9%.
  • The trailing P/E ratio of 5.2x trades at a sharp discount to the US-listed Financial Services peer median of 12.1x.
  • Share buybacks totaled $20.0M in FY2025, contributing to a 17.1% reduction in shares over five years.

Bear case

  • Analysts forecast revenue to fall 21.3% to $204.1M and EPS to decline 54.9% to $2.60 in the next fiscal year.
  • The stock's forward P/E of 13.7x is higher than the US-listed Financial Services peer median of 10.8x.
  • Short interest represents 11.7% of the company's total float.

What Carter Bankshares does

Carter Bankshares, Inc., founded in 1974 and headquartered in Martinsville, Virginia, serves as the bank holding company for Carter Bank & Trust. The company provides a range of deposit products, including checking, savings, retirement accounts, money market accounts, and certificates of deposit. Its loan offerings feature secured and unsecured commercial loans, consumer loans for automobiles, education, and home improvements, alongside residential mortgages, real estate construction and acquisition loans, and home equity lines of credit. It also offers credit cards, treasury and corporate cash management, safe deposit boxes, direct deposit, and digital banking tools including mobile banking and e-statements.

Growth and profitability

Annual revenue rose from $156.4M in FY2021 to $254.6M in FY2025, delivering a 5-year revenue CAGR of 9.2%. Net income fluctuated over this span, rising to $50.1M in FY2022 before settling at $23.4M in FY2023, $24.5M in FY2024, and $31.4M in FY2025. Gross margin was 61.7% in FY2025 compared with 84.1% in FY2021, while operating margin concluded FY2025 at 15.7%. Momentum accelerated in the quarter ended June 30, 2026, as quarterly revenue increased 68.3% year-over-year and quarterly earnings surged 253.9% year-over-year, supporting trailing twelve-month EPS of $5.80.

CARE income statement →

Balance sheet and cash flow

As of June 30, 2026, Carter Bankshares held $681.4M in cash and short-term investments, total assets of $4.80B, and shareholders' equity of $539.1M, with a current ratio of 0.01. During FY2025, operating cash flow reached $39.9M and free cash flow was $31.8M. Capital expenditures totaled $8.1M in FY2025. The company deployed $20.0M into share buybacks during FY2025, bringing its 5-year share count change to -17.1%.

CARE balance sheet →

Valuation and performance

Trading at $30.21, Carter Bankshares has a market capitalization of $699.8M and an enterprise value of $461.5M. The stock trades at a trailing P/E of 5.2x, lower than the median of 12.1x for its US-listed Financial Services peers, though its forward P/E of 13.7x is above the peer median of 10.8x. Its price-to-sales multiple is 2.4x versus 3.2x for peers. Over the trailing 1-year period, the stock returned 66.2% versus 16.8% for the S&P 500 (SPY), and its 5-year return reached 107.6% compared to 83.0% for the index.

CARE key metrics →

CARE dividend

Carter Bankshares pays an annual forward dividend of $0.40 per share, representing a dividend yield of 1.32% on a quarterly distribution schedule. The dividend is supported by a payout ratio of 12.5%, and the most recent ex-dividend date occurred on August 10, 2026.

What analysts expect

Consensus analyst coverage consists of 1 Strong Buy and 3 Hold ratings. The mean price target is $35.08, representing a 16.1% upside compared to the last close of $30.21. For the current fiscal year ending December 31, 2026, analysts estimate EPS of $5.76 on revenue of $259.5M. For the following fiscal year, 4 analysts forecast EPS to fall 54.9% to $2.60 and revenue to decline 21.3% to $204.1M. Carter Bankshares has surpassed EPS estimates in 2 of the past 4 quarters, and its next earnings date is October 22, 2026.

CARE forecast and price target →

Key risks and what to watch

  • Consensus estimates project a sharp 54.9% decline in earnings per share for the next fiscal year.
  • The bank's current ratio sits at 0.01 as of June 30, 2026, reflecting large deposit and short-term obligations.
  • Carter Bankshares met or exceeded consensus EPS expectations in only 2 of the prior 4 quarters.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this CARE AI stock analysis

This page is an AI-written research summary of Carter Bankshares, Inc. (CARE). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CARE income statement, CARE balance sheet, CARE key metrics, CARE analyst forecast, CARE chart. See the CARE stock overview for the latest quote and news.

CARE AI stock analysis FAQ

What dividend does Carter Bankshares pay?

The company pays a quarterly dividend totaling $0.40 per year, which equates to a 1.32% forward yield and a 12.5% payout ratio.

When is the next earnings release for Carter Bankshares?

Carter Bankshares is scheduled to release its next quarterly financial results on October 22, 2026.

What are analysts' price targets for CARE?

The mean analyst price target is $35.08, which is 16.1% above the last closing price of $30.21.

How has Carter Bankshares performed compared to the S&P 500?

Over the past year, CARE returned 66.2% versus 16.8% for the S&P 500 (SPY), and over five years it returned 107.6% versus 83.0% for the benchmark.

More Financial Services AI stock analysis